Care

Effectiveness and feasibility of a simplified decentralised HCV testing and treatment model in primary healthcare settings, targeting high-risk groups in Malaysia. More

Feasibility, effectiveness and cost of a decentralized HCV care model among the general population in Delhi, India More

Outcomes of the CT2 study: A ‘one‐stop‐shop’ for community‐based hepatitis C testing and treatment in Yangon, Myanmar More

The World Health Organization released first-ever global guidance for countries seeking to validate elimination of hepatitis B and hepatitis C as a public health problem. More

HRI released its annual Global State of Harm Reduction report monitoring harm reduction services on the ground, where possible, and how people who use drugs have been impacted by COVID-19. More

An issue brief, developed by TAG and Médecins du Monde based on crowdsourced hepatitis C data, provides supplemental evidence for advocates on hepatitis C treatment uptake and care among PWID. More

The HCV program in Rwanda could be a model for resource-limited settings with the right combination of a proactive Ministry of Health, and an emphasis on community-based response. More

Pakistan has the second highest global burden of HCV infection, with 5% of the population living with HCV. People’s illnesses or deaths have an enormous economic impact. More

The Handbook describes the HCV treatment project targeting people who inject drugs implemented in Tbilisi, Georgia by Médecins du Monde, New Vector and the medical center Neolab. More

An estimated 80 million people are living with chronic hepatitis C globally and millions are newly infected every year. WHO attributes an estimated 700,000 deaths to hepatitis C. More